Jinyang.com News Reporter Yu Baozhu reported: The exchanges and cooperation between Dongguan and Taiwan's biological industries have been further strengthened, and another batch of "Rongguan Plan" enterprises have signed contracts and settled in Songshan Lake . On November 8, Xuan Mingzhi, honorary vice chairman of Taiwan Lianhua Electronics Group and chairman of Taiwan Cross-Strait Biotechnology Industry Development Promotion Association, and his delegation officially held the "Rongguan Plan" enterprise signing ceremony at the Songshan Lake Management Committee. Song Tao, the municipal government consultant and chairman of Dongguan Biotechnology Industry Development Co., Ltd., officially signed a contract with two Taiwanese counter-invested companies, Murad Garje Biotechnology Co., Ltd. and Shuangmei Biotechnology Co., Ltd., respectively. Another batch of Taiwanese high-quality biotechnology companies were selected for the "Rongguan Plan". At this point, the "Rongguan Plan" has successfully introduced companies such as Hugui and Jinhong to register and settle in Songshan Lake.
It is understood that the seven Taiwanese biotechnical companies that have settled in involve multiple sub-biological industries such as medical devices, IVD (in vitro diagnostic products), health food, beauty and cosmetics, and are representative of Taiwan's biotechnical industries, and there are also leading companies in Taiwan's sub-biological industries, including three listed companies in Taiwan.
According to Song Tao's consultant, the "Rongguan Plan" is a means of government innovation to attract investment. The entry of this group of high-quality Taiwanese biotechnical companies shows that the "Rongguan Plan" has been recognized by the market. Through the demonstration effect, more well-known Taiwanese biotechnical companies will be driven to settle in Dongguan . Next, in addition to increasing promotion efforts, Dongguan will also serve biotechnology companies that have settled in, and strive to achieve revenue in the mainland as soon as possible, so as to promote the development and growth of enterprises in the mainland.
Dongguan established a cross-strait biotechnology industry cooperation base in 2012 to officially strategically plan the bioindustry. After more than three years of development, the base now gathers 196 biotechnology companies including Dongyangguang Pharmaceutical and Pan Asia Pacific, and the industrial agglomeration trend of sub-industry such as medical devices, pharmaceuticals and health products is obvious. Dongguan itself has a complete industrial chain supporting facilities and convenient raw material supply. Combined with Taiwan's leading advantages in the development of the ICT industry for many years, the two sides will have complementary advantages in the biological sub-sectors such as Internet medical care and medical devices, and have a unique environment for the development of biotechnology. Therefore, the Dongguan Municipal Government launched the "Rongguan Plan" to promote and accelerate the settlement of high-quality Taiwanese biotech enterprises in Dongguan. It plans to introduce 20 mature biotech enterprises with certain strength in Taiwan, which have been listed or entered the IPO stage within three years after the launch, and the entry can be achieved immediately.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-